Sign in
Create a Profile
Previous
A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Tumor Malignancies
Diseases and Conditions Researched
Advanced Solid Cancers
Participation Guidelines
Age: 18 Years and older
Gender: Both
Gender: Both
Click here for detailed participation information for this trial.
| Sponsor: | AstraZeneca |
|---|---|
| Study HIC#: | 1107008821 |
How will my information be used?
For more information about this trial, contact:
Noelle Sowers
203-737-3472
noelle.sowers@yale.edu
Principal Investigator
Howard S Hochster
Cancer Center
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
